BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36751636)

  • 21. FGF19 genetic amplification as a potential therapeutic target in lung squamous cell carcinomas.
    Zhang X; Kong M; Zhang Z; Xu S; Yan F; Wei L; Zhou J
    Thorac Cancer; 2017 Nov; 8(6):655-665. PubMed ID: 28906590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression.
    Xu Y; Zhang Q; Miao C; Dongol S; Li Y; Jin C; Dong R; Li Y; Yang X; Kong B
    Cancer Med; 2019 Jan; 8(1):351-362. PubMed ID: 30565428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin‑resistant ovarian cancer.
    Xie Y; Peng Z; Shi M; Ji M; Guo H; Shi H
    Mol Med Rep; 2014 Nov; 10(5):2346-50. PubMed ID: 25118792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of LC3-dependent protective autophagy in ovarian cancer cells by protein phosphatase 2A.
    Yin X; Zhang N; Di W
    Int J Gynecol Cancer; 2013 May; 23(4):630-41. PubMed ID: 23518861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells.
    Bao L; Jaramillo MC; Zhang Z; Zheng Y; Yao M; Zhang DD; Yi X
    Mol Med Rep; 2015 Jan; 11(1):91-8. PubMed ID: 25322694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B.
    Xiao F; Li Y; Wan Y; Xue M
    Cancer Chemother Pharmacol; 2018 May; 81(5):935-947. PubMed ID: 29594361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. shRNA-mediated AMBRA1 knockdown reduces the cisplatin-induced autophagy and sensitizes ovarian cancer cells to cisplatin.
    Li X; Zhang L; Yu L; Wei W; Lin X; Hou X; Tian Y
    J Toxicol Sci; 2016 Feb; 41(1):45-53. PubMed ID: 26763392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.
    McEvoy LM; O'Toole SA; Spillane CD; Martin CM; Gallagher MF; Stordal B; Blackshields G; Sheils O; O'Leary JJ
    BMC Cancer; 2015 Jul; 15():547. PubMed ID: 26205780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
    Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
    Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of BRCA2 enhances cisplatin and cisplatin-induced autophagy in ovarian cancer cells.
    Wan B; Dai L; Wang L; Zhang Y; Huang H; Qian G; Yu T
    Endocr Relat Cancer; 2018 Jan; 25(1):69-82. PubMed ID: 29066501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Damnacanthal isolated from morinda species inhibited ovarian cancer cell proliferation and migration through activating autophagy.
    Li R; Li H; Lan J; Yang D; Lin X; Xu H; Han B; Yang M; Su B; Liu F; Jiang W
    Phytomedicine; 2022 Jun; 100():154084. PubMed ID: 35421676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nrf2 induced cisplatin resistance in ovarian cancer by promoting CD99 expression.
    Wu J; Zhang L; Li H; Wu S; Liu Z
    Biochem Biophys Res Commun; 2019 Oct; 518(4):698-705. PubMed ID: 31472965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of glucose regulated protein 78 on autophagy and apoptosis in ovarian epithelial carcinoma].
    Li M; Tian J; Qu Q
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):848-53. PubMed ID: 26887774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells.
    Lin JF; Lin YC; Tsai TF; Chen HE; Chou KY; Hwang TI
    Drug Des Devel Ther; 2017; 11():1517-1533. PubMed ID: 28553083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of autophagy in cisplatin resistance in ovarian cancer cells.
    Wang J; Wu GS
    J Biol Chem; 2014 Jun; 289(24):17163-73. PubMed ID: 24794870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA 1301 inhibits cisplatin resistance in human ovarian cancer cells by regulating EMT and autophagy.
    Yu JL; Gao X
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1688-1696. PubMed ID: 32141535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIF-1α-induced autophagy contributes to cisplatin resistance in ovarian cancer cells.
    Long F; Liu W; Jia P; Wang H; Jiang G; Wang T
    Pharmazie; 2018 Sep; 73(9):533-536. PubMed ID: 30223937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MKNK2 enhances chemoresistance of ovarian cancer by suppressing autophagy via miR-125b.
    Wang J; Da C; Su Y; Song R; Bai Z
    Biochem Biophys Res Commun; 2021 Jun; 556():31-38. PubMed ID: 33836345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
    Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT
    Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells.
    Yan XY; Zhang Y; Zhang JJ; Zhang LC; Liu YN; Wu Y; Xue YN; Lu SY; Su J; Sun LK
    Cancer Sci; 2017 Jul; 108(7):1405-1413. PubMed ID: 28498503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.